↓ Skip to main content

Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the…

Overview of attention for article published in BMC Cancer, September 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
100 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer
Published in
BMC Cancer, September 2013
DOI 10.1186/1471-2407-13-425
Pubmed ID
Authors

Marcelo Madeira, André Mattar, Ângela Flávia Logullo, Fernando Augusto Soares, Luiz Henrique Gebrim

Mendeley readers

The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 1%
Portugal 1 1%
South Africa 1 1%
Unknown 97 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 17 17%
Student > Master 16 16%
Researcher 10 10%
Student > Bachelor 9 9%
Other 7 7%
Other 18 18%
Unknown 23 23%
Readers by discipline Count As %
Medicine and Dentistry 36 36%
Agricultural and Biological Sciences 12 12%
Biochemistry, Genetics and Molecular Biology 11 11%
Nursing and Health Professions 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 9 9%
Unknown 25 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2020.
All research outputs
#4,740,163
of 22,961,203 outputs
Outputs from BMC Cancer
#1,223
of 8,346 outputs
Outputs of similar age
#42,930
of 202,532 outputs
Outputs of similar age from BMC Cancer
#12
of 89 outputs
Altmetric has tracked 22,961,203 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,346 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 202,532 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.